FindTrial
Sign In

Evaluation of interleukin 9 levels in different stages of gum diseases.

Comparative evaluation of serum and salivary levels of interleukin (IL) 9 in subjects with gingivitis, periodontitis and in health.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017625
Enrollment
90
Registered
2019-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Control Intervention1: Interleukin 9: Interleukin 9 is pleotropic in function.It also plays a role in regulating immunity. It is a key driver of immune responses in chronic inflammatory diseases at mu

Sponsors

Panineeya institute of dental sciences and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: As evaluated by Russelâ??s periodontal index scoring, subjects diagnosed with gingivitis and periodontitis are included. Subjects who have not receive any periodontal treatment from past 6 months. Subjects having atleast 15 natural teeth remaining.

Exclusion criteria

Exclusion criteria: Subjects who have other systemic diseases. Subjects having a history of smoking. Subjects suffering from Aggressive periodontitis. Pregnant and lactating women. Mentally challenged and un-cooperative patients.

Design outcomes

Primary

MeasureTime frame
Serum and salivary Interleukin 9 levelsTimepoint: Serum and salivary Interleukin 9 levels were estimated for a period of 6 months—

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable—

Countries

India

Contacts

Public ContactP ABHIGNA

Panineeya institute of dental sciences and research centre

surya.prasanna@yahoo.com9440387830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026